New Search

If you are not happy with the results below please do another search

1271 search results for:

1171

Fully automated random access clinical chemistry analyser

The Chem 300 plus is a random access clinical chemistry analyser and provides an innovative solution for laboratories thanks to its two reagent plates and two arms. This new design, combined with 60 (30+30) positions in two different rotors, gives the lab the opportunity to work with two instruments, allowing the best possible organization and […]

1172

All-in-one instrument for molecular diagnostics

The geneLEAD VIII, manufactured by PSS and distributed by Diagenode Diagnostics in Europe, is a new all-in-one automated molecular diagnostics platform designed for carrying out small series of tests (1,000 to 4,000 tests/year), from nucleic acid extraction to patient result in 1,5 hour. This instrument can independently perform up to 8 different real-time PCR tests, […]

1173

Osmomat auto Freezing point osmometer

The design of the Osmomat auto is based on ten years of experience with the measuring principle of the Osmomat 030, the first cryoscopic osmometer that was launched by Gonotec for clinical application.  The company was.able to automate the draining of the measuring system so that it is possible to reliably obtain a high sample […]

1174

Hemoglobin and hematocrit meter system

The latest addition to the StatStrip line of handheld, hospital meters, the StatStrip Hemoglobin and Hematocrit Meter System (StatStrip Hb/ Hct), has gained CE mark certification and is now available in all CE regulated countries. StatStrip Hb/Hct is the only point-of-care (POC) meter to measure hemoglobin and hematocrit for accurate anemia screening and blood loss […]

1175

MicroRNA enzyme immunoassay

BioVendor has now launched hsa-miR-21-5p miREIA, a quantitative assay combining molecular diagnostics and immunoassay technology. MiRNA isolated from a patient sample is hybridized to a complementary biotinylated DNA oligonucleotide probe. The miRNA/DNA hybrids are then processed in an ELISA format in a microtitre plate coated with a monoclonal antibody specific to perfectly matched miRNA/DNA dimers. […]

1176

Ansh labs launches two new immunoassays for SARS-COV2

Ansh labs has launched two new immunoassays, SARS-CoV2 IgG and IgM ELISAs, to assist in the fight against the Covid-19 pandemic. Ansh Labs is releasing these two kits for sale in the United States under the provisions outlined in Section D of Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency. At […]

1177

Porvair Sciences expands range of black microplates

Porvair Sciences has expanded its range of high quality, black microplates that minimise sample degradation by exposure to light, even over long storage periods. Available in a choice of 48-, 96- and 384-well formats – the black plates are precisely manufactured to applicable ANSI / SLAS dimensions ensuring complete compatibility with almost all readers and […]

1178

ELISA for urinary sCD163 measurement

Urinary soluble CD163 (sCD163) is a novel non-invasive marker of renal inflammation, and its determination supports early detection and monitoring of active glomerulonephritis (GN). Studies by experts in the field led by Prof. Mark Little (Trinity College, Dublin, Ireland) showed that significantly increased sCD163 levels in urine are present in up to 87% of patients […]

1179

Horizon Discovery CHOSOURCE platform supports development of immunotherapy for autoimmune diseases

Horizon Discovery Group, a leader in the application of gene editing and gene modulation for cell line engineering, says its cGMP-compliant CHOSOURCE™ platform has played a key role in generating a stable cell line for the development of an immunotherapy for autoimmune diseases. Horizon’s pharmaceutical-grade, stable Chinese Hamster Ovary (CHO) cells delivered high yields of […]

1180

Randox diabetes testing portfolio

Type 2 diabetes mellitus (T2DM) now attains the status of global pandemic, spreading from developed to developing countries. The epidemiological trends indicate that the prevalence will continue to increase dramatically. The World Health Organization estimates diabetes to be the seventh global leading cause of death, accounting for 1.6 million deaths in 2016. Randox is committed […]